Background Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation
technique. When stimulation is applied over the primary motor cortex and coupled with …

Alzheimer's disease (AD) is the commonest neurodegenerative disease with slow
progression. Pieces of evidence suggest that the GABAergic system is impaired in the early …

Although amyloid β (Aβ) and tau aggregates define the neuropathology of Alzheimer's
disease (AD), TDP-43 has recently emerged as a co-morbid pathology in more than half of …

In the present theoretical review we will perform a critical surveillance of linguistic and
semantic processing in Mild Cognitive Impairment and Alzheimer's disease, explicitly …

Aging is the major risk factor for Alzheimer's disease (AD). Mitochondrial dysfunction and
neuronal network hyperexcitability are two age-related alterations implicated in AD …

There is growing interest in the investigation of ketogenic diets as a potential therapy for
bipolar disorder. The overlapping pharmacotherapies utilized for both bipolar disorder and …

Background Alterations in functional connectivity have been demonstrated in Alzheimer's
disease (AD), an age-progressive neurodegenerative disorder that affects cognitive function; …

Among the central features of Alzheimer's disease (AD) progression are altered levels of the
neuropeptide somatostatin (SST), and the colocalisation of SST-positive interneurons (SST …

Parvalbumin expressing (PV+) GABAergic interneurons are fast spiking neurons that
provide powerful but relatively short-lived inhibition to principal excitatory cells in the brain …

The goal of the treatment for Alzheimer's dementia (AD) is the cure of dementia. A literature
review revealed 18 major elements causing AD and 29 separate medications that address …